BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
FABP1
,
Metabolism of xenobiotics
,
Influenza
,
Hypothalamus
,
Amniocentesis
,
Lipitor
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
p10
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Uterus
Adrenal gland cortex
Kidney cortex
Myometrium
Kidney
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Infectious disease of lung
Lower respiratory tract infection
Pyloric ulcer
Middle East respiratory syndrome
Streptococcal infectious disease
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
tetrabromobisphenol A
Botulinum Toxins
Lipopeptides
Tretinoin
monobutyl phthalate
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
SOX21
VGLL4
PIP
SLC25A4
RAB5C
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
ZNF503 combined with GATA3 is a prognostic factor in triple-negative breast cancer.
Zfp503/Nlz2 Is Required for RPE Differentiation and Optic Fissure Closure.
Nolz1 expression is required in dopaminergic axon guidance and striatal innervation.
MicroRNA-340-5p suppresses non-small cell lung cancer cell growth and metastasis by targeting ZNF503…
The Fgf9-Nolz1-Wnt2 axis regulates morphogenesis of the lung.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
To Demonstrate Equivalence of Pharmacokinetics and Noninferiority of Efficacy for CT-P10 in Comparis…
Long-Term Efficacy and Safety of CT-P10 in Patients With RA
To Compare Efficacy and Safety Between CT-P10 and Rituxan in Patients With Low Tumour Burden Follicu…
Phase 2, Multi-center, Randomized, Double- Masked and Placebo-Controlled Study of YP-P10 Ophthalmic …
Provide Initial Evidence of Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy to Support the …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ